Allied Cement’s Chinese Pharmaceutical Company Acquisition

March 01, 2016

Hong Kong (March 1, 2016) – Paul Hastings LLP, a leading global law firm, announced today that it represented Allied Cement Holdings Limited, a leading China-based cement manufacturing and trading company, to acquire 60% equity interests of Beijing Ziguang Pharmaceutical Co., Ltd. from Shenzhen Waranty Asset Management Co., Ltd. for US$44 million.
The acquisition is part of Allied Cement’s business strategy to expand into the medical, pharmaceutical and healthcare industry.

The Paul Hastings team was led by Raymond Li, partner and Chair of Greater China, with support from partner Pei Fang, associates Bonnie Kong, Matt Li and trainee solicitor Tiffany Lam.

At Paul Hastings, our purpose is clear — to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.